According to Lancelot D Cunha CEO of Sharyans Wealth Management, one may buy Jet Airways with a target of Rs 320 and Ranbaxy Laboratories with a target of Rs 447.

SP Tulsian cautious on Ranbaxy Laboratories

SP Tulsian of sptulsian.com is cautious on Ranbaxy Laboratories. "One may take the contrarian view, when it goes up one can short at about Rs 445-450 and when it goes down at Rs 405-415 where the long can be created as a positional trader with expiry view," he adds.

Bull's Eye: Buy JP Power, Hindalco, Ranbaxy, Jet Airways

Shahina Mukadam of Varun Capital advised buying Hindalco Industries with a target price of Rs 115 and SAIL with a target price of Rs 49.

Ranbaxy Labs may test Rs 380-390: SP Tulsian

SP Tulsian of sptulsian.com os of the view that Ranbaxy Laboratories may correct to Rs 380-390 and feels that the stock may also bounce back to Rs 420-430 level in this series itself.

Book some profits in Ranbaxy around Rs 415-420: Paul

According to Abhijit Paul, Founder of Alphative Advisors LLP, one may book some profits in Ranbaxy Laboratories around Rs 415-420.

Trading calls on Titan, Sun TV, Mcleod Russel, Ranbaxy

ICICI Direct has a sell call on Titan with a target between Rs 211.50 and Rs 208. Their stop loss is at Rs 219.

6 intraday picks to make smart gains

Shardul Kulkarni of Angel Broking suggests buying MRF with a target at Rs 14000 and NMDC with a target at Rs 130.

SP Tulsian cautious on Ranbaxy Laboratories

SP Tulsian of sptulsian.com is cautious on Ranbaxy Laboratories for the September series.

Hold Ranbaxy Laboratories: Dilip Bhat

Dilip Bhat, Joint MD of Prabhudas Lilladher is of the view that one may hold Ranbaxy Laboratories.

Buy Ranbaxy Laboratories, advises Sudarshan Sukhani

According to Sudarshan Sukhani of s2analytics.com, one may buy Ranbaxy Laboratories. "One should trade it on the long side only if there is a sense that markets are relatively quiet today," he adds.

Ranbaxy may touch Rs 420-425 in near term: Kulkarni

Shardul Kulkarni of Angel Broking is of the view that Ranbaxy Laboratories may touch Rs 420-425 over the next couple of trading sessions.

Check Out: Super Six stocks for August 19

Rajesh Jain of Religare Securities advices buying Ranbaxy Laboratories with target of Rs 415 and selling DLF with a target of Rs 135.

Buy Ranbaxy Laboratories on declines: Shardul Kulkarni

According to Shardul Kulkarni, Sr Technical Analyst at Angel Broking, one may buy Ranbaxy Laboratories on declines. "In the next two-two and a half months the stock may move around Rs 420-440," he adds.

Worst over for Ranbaxy; buy Lupin on dips: Antique Broking

Anmol Ganjoo of Antique Stock Broking is upbeat on Lupin and Ranbaxy. He expects these stocks to perform well going ahead. On the other hand, he not so confident about Wockhardt's performance.

Buy Ranbaxy above Rs 290: Sanjeev Agarwal

According to Sanjeev Agarwal, CEO of Dynamix Research & Capital Management, one may buy Ranbaxy Laboratories above Rs 290.

Short Ranbaxy Laboratories: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com is of the opinion that one may sell Ranbaxy Laboratories as downside momentum is just starting in it.

Sell Ranbaxy Laboratories: Jagannadham Thununguntla

Jagannadham Thununguntla, Strategist & Head of Research, SMC Global Securities recommends selling Ranbaxy Laboratories as there are more downsides in the stock and it can head to Rs 250.

Buy Reliance Communications; sell Ranbaxy Labs: Sukhani

Sudarshan Sukhani of s2analytics.com recommends buying Reliance Communications (RComm) and advises selling Ranbaxy Laboratories.

Give Ranbaxy time to fix issues; bullish on Lupin: Antique

Anmol Ganjoo, pharma analyst, Antique Stock Broking says one should give the company time to fix the various problems in its US business and wait before taking a view unless one sees an improvement on ground.

Sell Ranbaxy Laboratories: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com recommends to sell Ranbaxy Laboratories.

6 stock ideas to liven up your trade

According to Manas Jaiswal of manasjaiswal.com one can buy Ranbaxy Laboratories at current levels with stop loss of Rs 335.

Sell Ranbaxy Laboratories on pullback: Hemant Thukral

Hemant Thukral of Aditya Birla Money says one may short Ranbaxy Labs around Rs 325-330 levels.

Sell Ranbaxy Laboratories, says Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com recommends selling Ranbaxy Laboratories in strength or on a consolidation.

Frontline stocks and midcaps may face pressure: Bhatnagar

Vineet Bhatnagar, MD of PhillipCapital says that HDFC, ICICI Bank, HDFC Bank, Ranbaxy Laboratories, Sun Pharma and other front-line stocks could face some pressure in the last half hour of trade today.

Avoid Ranbaxy Laboratories: Sandip Sabharwal

Sandip Sabharwal of Prabhudas Lilladher advises to avoid Ranbaxy Laboratories and focus on the companies which are actually doing well.